L3MBTL1
Lethal(3)malignant brain tumor-like protein 1
Also known as: dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, LMBL1_HUMAN, ZC2HC3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y468
- Gene
- L3MBTL1
- Ensembl
- ENSG00000185513
- Chromosome
- 20
- Canonical length
- 840 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear bodies,Midbody ring
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene represents a polycomb group gene. The encoded protein functions to regulate gene activity, likely via chromatin modification. The encoded protein may also be necessary for mitosis. Alternatively spliced transcript variants encoding different isoforms have been identified.[provided by RefSeq, Sep 2010]
Canonical amino-acid sequenceUniProt
840 residues, UniProt reviewed canonical sequence.
>Q9Y468|L3MBTL1
1 MHLVAGDSPG SGPHLPATAF IIPASSATLG LPSSALDVSC FPREPIHVGA PEQVAGCEPV
61 SATVLPQLSA GPASSSTSTV RLLEWTEAAA PPPGGGLRFR ISEYKPLNMA GVEQPPSPEL
121 RQEGVTEYED GGAPAGDGEA GPQQAEDHPQ NPPEDPNQDP PEDDSTCQCQ ACGPHQAAGP
181 DLGSSNDGCP QLFQERSVIV ENSSGSTSAS ELLKPMKKRK RREYQSPSEE ESEPEAMEKQ
241 EEGKDPEGQP TASTPESEEW SSSQPATGEK KECWSWESYL EEQKAITAPV SLFQDSQAVT
301 HNKNGFKLGM KLEGIDPQHP SMYFILTVAE VCGYRLRLHF DGYSECHDFW VNANSPDIHP
361 AGWFEKTGHK LQPPKGYKEE EFSWSQYLRS TRAQAAPKHL FVSQSHSPPP LGFQVGMKLE
421 AVDRMNPSLV CVASVTDVVD SRFLVHFDNW DDTYDYWCDP SSPYIHPVGW CQKQGKPLTP
481 PQDYPDPDNF CWEKYLEETG ASAVPTWAFK VRPPHSFLVN MKLEAVDRRN PALIRVASVE
541 DVEDHRIKIH FDGWSHGYDF WIDADHPDIH PAGWCSKTGH PLQPPLGPRE PSSASPGGCP
601 PLSYRSLPHT RTSKYSFHHR KCPTPGCDGS GHVTGKFTAH HCLSGCPLAE RNQSRLKAEL
661 SDSEASARKK NLSGFSPRKK PRHHGRIGRP PKYRKIPQED FQTLTPDVVH QSLFMSALSA
721 HPDRSLSVCW EQHCKLLPGV AGISASTVAK WTIDEVFGFV QTLTGCEDQA RLFKDEARIV
781 RVTHVSGKTL VWTVAQLGDL VCSDHLQEGK GILETGVHSL LCSLPTHLLA KLSFASDSQYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against L3MBTL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 14 nTPM
- pituitary gland: 11 nTPM
- hypothalamus: 11 nTPM
- cerebral cortex: 9.7 nTPM
- hippocampal formation: 7.1 nTPM
- amygdala: 6.8 nTPM
Single-cell type
- oligodendrocytes: 35 nCPM
- oligodendrocyte progenitor cells: 31 nCPM
- brain inhibitory neurons: 31 nCPM
- other brain neurons: 31 nCPM
- brain excitatory neurons: 30 nCPM
- distal convoluted tubule cells: 25 nCPM
Immune cell
- NK-cell: 0.2 nTPM
- memory CD4 T-cell: 0.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- hypothalamus: 12 nTPM
- midbrain: 9.4 nTPM
- pons: 9.4 nTPM
- cerebral cortex: 9.3 nTPM
- basal ganglia: 9.1 nTPM
- medulla oblongata: 8.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about L3MBTL1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 154 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0
- gnomAD missense Z
- 1
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin organization
- constitutive heterochromatin formation
- hemopoiesis
- heterochromatin formation
- negative regulation of DNA-templated transcription
- regulation of cell cycle
- regulation of megakaryocyte differentiation
- regulation of mitotic nuclear division
Molecular functions
- chromatin binding
- histone binding
- histone H1K26me1 reader activity
- histone H1K26me2 reader activity
- histone H4K20me2 reader activity
- identical protein binding
- nucleosome binding
- SAM domain binding
- zinc ion binding
- histone H1 reader activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, C2H2C-type
- Mbt repeat domain
- Zinc finger, C2H2C-type superfamily
- Polycomb group and chromatin remodeling factors
- Zinc finger, C2HC type
- mbt repeat
- Lethal(3)malignant brain tumor-like protein 1, first MBT repeat
- Lethal(3)malignant brain tumor-like protein 1, third MBT repeat
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of L3MBTL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads L3MBTL1 as an antibody target. Whether an autoantibody or antibody against L3MBTL1 could matter depends on whether native L3MBTL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
L3MBTL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label L3MBTL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...